衰弱指数预测头颈癌患者再入院
基于2017年全国再入院数据库,纳入14420例接受头颈癌大手术患者,评估医院衰弱风险评分(HFRS)等对30天非计划再入院和死亡的预测价值。HFRS≥5者占22%,再入院率18.0%对9.5%,多变量OR为1.59(95%CI 1.37-1.85)。
要点
- HFRS≥5的衰弱患者30天再入院风险显著增高,OR为1.59。
- 年龄>75岁和电解质紊乱也是再入院的独立危险因素。
核心结论
- 在头颈癌手术人群中,HFRS可显著预测30天非计划再入院。
研究设计与样本
- 回顾性数据库分析,使用2017年全国再入院数据库,覆盖116家医疗中心。
- 纳入接受头颈癌大手术的患者共14420例,采用双变量和多变量逻辑回归分析。
主要发现
- 30天非计划再入院率为11%,最常见原因为手术并发症(26.5%)、脓毒症(7.3%)和呼吸衰竭(3.9%)。
- HFRS≥5者占22%,其30天再入院率为18.0%,显著高于非衰弱者的9.5%(P<.01)。
- 多变量模型中衰弱与再入院的OR为1.59(95%CI 1.37-1.85)。
- 衰弱患者住院天数更多(8.2对6.8天,P=.02),住院总费用更高(275000对188000美元,P<.01)。
- 年龄>75岁(OR 1.26 [95%CI 1.03-1.55])和电解质紊乱(OR 1.25 [95%CI 1.07-1.46])与再入院显著相关。
临床怎么用
- HFRS可作为头颈癌术后再入院的潜在风险分层工具,辅助识别高危患者。
局限性
- HFRS需与其他风险分层方法比较,并在其他癌症人群中探索。
- 需进一步研究旨在减少再入院的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the predictive utility of the Hospital Frailty Risk Score (HFRS), a stratification tool based on the ICD-10 (International Classification of Disease, Tenth Revision), and other risk factors for 30-day readmissions and mortality in a nationally representative cohort. STUDY DESIGN: Retrospective database review. SETTING: Nationwide Readmissions Database (2017). METHODS: Patients with head and neck cancer who underwent major surgical procedures were identified from the 2017 Nationwide Readmissions Database, representing 116 medical centers nationwide. Bivariate and multivariable logistic regression methods were used to identify factors associated with unplanned 30-day readmission, 30-day readmission mortality, and increased length of hospital stay. RESULTS: A total of 14,420 patients underwent major head and neck cancer surgery. Unplanned readmission occurred in 11% of patients. The most common reasons for unplanned readmission were procedural complications (26.5%), sepsis (7.3%), and respiratory failure (3.9%). Elevated frailty index (HFRS ≥5) was identified in 22% of patients. Frailty was associated with higher 30-day readmission rates (18.0% vs 9.5%, P < .01), which held on multivariate modeling (odds ratio [OR], 1.59 [95% CI, 1.37-1.85]). Frail patients spent more days in the hospital (8.2 vs 6.8, P = .02) and incurred more charges across hospital stays ($275,000 vs $188,000, P < .01). Patients >75 years old (OR, 1.26 [1.03-1.55]) and patients with electrolyte abnormalities (OR, 1.25 [1.07-1.46] were significantly more likely to be readmitted. CONCLUSION: In this head and neck cancer surgical population, HFRS significantly predicted unplanned readmission. HFRS is a potential risk stratification tool and should be compared with other methods and explored in other cancer populations. Beyond the challenge of identifying at-risk patients, future work should explore potential interventions aimed at mitigating readmission.
引用
- Voora RS, Qian AS, Kotha NV, et al. Frailty Index as a Predictor of Readmission in Patients With Head and Neck Cancer. Otolaryngol Head Neck Surg. 2021. PMID: 34520305. doi:10.1177/01945998211043489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。